ACTISORB™ Silver 220 Antimicrobial Binding Dressing

Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.

Don’t Just Mask the Odor,
Address the Cause

ACTISORB™ Silver 220 Dressing is an activated charcoal dressing with silver, enclosed in a non-adherent nylon sleeve. Traps odor while providing an effective barrier to bacterial penetration, which may help reduce infection. 


Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Healthcare providers should review the product User Manual, Safety Information and/or
 Instructions for Use prior to application.





  • Overview
  • How it Works
  • Indications & Applications
  • Evidence & Outcomes
  • Ordering

Overview

Traps Odor


By eliminating offensive odors, ACTISORB™ Silver 220 Dressing helps improve the patient’s quality of life.1,2,3

Activated charcoal binds bacteria and toxins in the dressing

Antimicrobial activity within the dressing is proven effective* against 150 microorganisms associated with wound infection.4


*in vitro data on file.

Kills Bacteria


The silver has been proven to kill bacteria* and participate in the reduction of bioburden in the dressing.3


*in vitro data on file.

 

How it Works

  • ABOUT
  • SPECIFICATIONS
  • MATERIALS FOR DOWNLOAD

Traps odor while protecting against infection


ACTISORB™ Silver 220 Dressing is in a class apart from other charcoal dressings. Its triple action traps odor while addressing its cause.

  • Activated charcoal traps odor in the dressing6
  • Activated charcoal binds bacteria and toxins that impair the healing process6
  • Silver kills the bacteria in the dressing5


Antimicrobial Action

  • ACTISORB™ Silver 220 Dressing is effective against 150 microorganisms associated with wound infection.4


Odour and Exudate Management

  • ACTISORB™ Silver 220 Dressing eliminates offensive odors and so improves the patient’s quality of life.5
  • The dressing also manages any exudates while helping to maintain a moist wound-healing environment.1,2,3,7 
ACTISORB™ Silver 220 Dressing
ACTISORB™ Silver 220 Dressing is a sterile primary dressing, comprised of activated charcoal cloth, impregnated with silver, within a spun bonded nylon envelope.

Indications & Applications

  • INDICATIONS
  • APPLICATIONS

Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Healthcare providers should review the product User Manual, Safety Information and/or Instructions for Use prior to application

 

ACTISORB™ Silver 220 Dressing provides an effective barrier to bacterial penetration and for adsorbing offending odor resulting from wounds; the binding properties of the dressing trap bacteria, bacterial toxins and odor.
 

ACTISORB™ Silver 220 Dressing is suitable for use under compression bandaging. 

 

Contraindications
ACTISORB™ Silver 220 Dressing should not be used on third-degree burns. 

Warnings

  • Should not be used on patients with a known sensitivity to silver.
  • For external use only.

Precautions
  • This product should not be cut, otherwise particles of activated charcoal may get into the wound and cause discoloration.
  • The dressing performance may be impaired by excess use of petrolatum based ointments.
  • Clinicians/Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates

 

 

 

Before Application
Always refer to the instructions for use for full details. Select a size of ACTISORB™ Silver 220 Dressing that is slightly larger than the wound. Prepare the wound according to appropriate wound management protocol. Before application of the dressing ensure that any necrotic tissue is removed by debridement. 

Dressing Preparation
1. Carefully remove the dressing from the pouch using the aseptic technique and forceps.
2. If necessary you can fold the dressing to fit the wound shape. ACTISORB™ Silver 220 Dressing should not be cut, otherwise particles of activated carbon may get into the wound and cause discolouration.
 
ACTISORB™ Silver 220 Dressing STEP 01 User Guide
Dressing Application
1. Gently apply ACTISORB™ Silver 220 Dressing to the wound. Either side of ACTISORB™ Silver 220 dressing can be placed on the wound. The properties of the dressing are most fully utilised when ACTISORB™ Silver 220 Dressing makes direct contact with the wound. 
ACTISORB™ Silver 220 Dressing STEP 02 User Guide
Secondary Dressing Application
1. Cover and secure ACTISORB™ Silver 220 Dressing with a secondary dressing such as TIELLE LIQUALOCK™ Dressings. Choose the secondary dressing based on the level of exudate. If required, the dressing may be held in place to aid application. 
ACTISORB™ Silver 220 Dressing STEP 03 User Guide
Dressing Change And Removal
1. ACTISORB™ Silver 220 Dressing can remain on the wound for up to 7 days, depending on the level of exudate. The secondary absorbent dressing can be changed as required.
2.Gently remove the secondary dressing.
3.Gently remove ACTISORB™ Silver 220 Dressing from the wound bed and discard
ACTISORB™ Silver 220 Dressing STEP 04 User Guide

Do not re-use.
Do not re-sterilize.
Do not use if package is damaged.
The use by date of this product is printed on the packaging.

Caution: Federal Law (USA) restricts this device to sale by or on the order of a properly licensed healthcare practitioner. This caution is not applicable outside the U.S.

 

 

Evidence & Outcomes

The efficacy of ACTISORB™ Silver 220 Dressing is supported by a body of clinical and in vitro evidence.
Acelity Clinical Evidence is a resource for healthcare professionals to explore preclinical, clinical, and review articles discussing the use of KCI and Systagenix products. Use our powerful search tool to customize your view of the Acelity product evidence.


For questions or to request published literature contact Medical Information

Clinical Evidence

Additional summary of evidence and outcomes.
TITLE A Comparison of the Antimicrobial Properties of Silver Dressings for Chronic Wound Care
View Abstract on PubMed
STUDY TYPE All levels
DATE 2002
AUTHORS Addison, et al.
TITLE Use of Actisorb* dressings over a skin-grafted infected wound. Burns
View Abstract on PubMed
STUDY TYPE All levels
DATE 2011
AUTHORS Karonidis A, et al.
TITLE Antimicrobial efficacy of silver impregnated activated charcoal wound dressing
View Abstract on PubMed
STUDY TYPE All levels
DATE 2003
AUTHORS Rennison, et al.
TITLE A case study to demonstrate use of charcoal dressings with silver on MRSA-infected wound.
View Abstract on PubMed
STUDY TYPE All levels
DATE 2001
AUTHORS Jackson, et al.
TITLE Use of a charcoal dressing with silver on an MRSA-infected wound
View Abstract on PubMed
STUDY TYPE All levels
DATE 2001
AUTHORS Jackson, et al.
TITLE Survey of 12,444 patients with chronic wounds treated with ACTISORB™ Silver 220
View Abstract on PubMed
STUDY TYPE All levels
DATE 2002
AUTHORS Stadler, et al.
TITLE PEG site infections: a novel use for Actisorb Silver 220
View Abstract on PubMed
STUDY TYPE All levels
DATE 2002
AUTHORS Leak, et al.
TITLE The effect of ACTISORB™ on chronic wounds with no clinical signs on infection.
View Abstract on PubMed
STUDY TYPE All levels
DATE 2004
AUTHORS Soriano, et al.
TITLE PEG site infections: a novel use for Actisorb Silver 220
View Abstract on PubMed
STUDY TYPE All levels
DATE 2002
AUTHORS Leak K. 
TITLE Effects of activated charcoal dressings on healing outcomes of chronic wounds
View Abstract on PubMed
STUDY TYPE Level 1
DATE 2010
AUTHORS Kerihuel JC.
TITLE Actisorb Silver 220: a unique antibacterial dressing
View Abstract on PubMed
STUDY TYPE All levels
DATE 2002
AUTHORS Hampton, et al.
TITLE Effect of ACTISORB™ on healing outcomes of chronic wounds
View Abstract on PubMed
STUDY TYPE All levels
DATE 2010
AUTHORS Kerihuel, et al.
TITLE Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220
View Abstract on PubMed
STUDY TYPE All levels
DATE 2003
AUTHORS Müller G, et al.
TITLE The efficacy of silver-impregnated activates charcoal dressings in the management of malodourous critically colonized chronic venous leg ulcers and diabetic foot ulcers.
View Abstract on PubMed
STUDY TYPE All levels
DATE 2014
AUTHORS Turton K, et al.

Ordering

To order any of the products listed below, please contact your KCI representative or call your local KCI Office. Click here to view our locations. 

 

Product Codes